C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2001
10/18/2001	DE10016877A1 (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung (Glyco) proteins with high immunoreactivity, and a method for their preparation
10/18/2001	DE10016527A1 Verfahren zur Diagnose von Krebserkrankungen und/oder neurodegenerativen Krankheitszuständen sowie Produkte dafür A method for diagnosing cancer and / or neurodegenerative disease states as well as products for
10/18/2001	DE10015906A1 Directed gene transfer to eukaryotic cells, useful for antisense inhibition of specific genes, comprises using a complex of polyethyleneimine, nucleic acid and monoclonal antibodies
10/18/2001	DE10007234A1 Peptid und dafür kodierende Nukleinsäure zur Bestimmung, Diagnostik und Therapie von Erkrankungen des Nervensystems Peptide and nucleic acid coding for determining diagnosis and treatment of diseases of the nervous system
10/18/2001	CA2406448A1 Identification of a human gaba transporter
10/18/2001	CA2406033A1 Anti-d monoclonal antibodies
10/18/2001	CA2405912A1 Albumin fusion proteins
10/18/2001	CA2405800A1 Novel secreted protein
10/18/2001	CA2405730A1 Serine-threonine kinase
10/18/2001	CA2405725A1 Identification of a novel dual specificity phosphataes
10/18/2001	CA2405637A1 Novel antibodies specifically identifying inactive psa, and uses thereof
10/18/2001	CA2405181A1 Human pyruvate dehydrogenese phosphatase
10/18/2001	CA2405124A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof
10/18/2001	CA2405104A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	CA2405083A1 New bromodomain protein
10/18/2001	CA2405029A1 Detection of erythropoietin and erythtropoietin receptor
10/18/2001	CA2404988A1 Listeria monocytogenes genome, polypeptides and uses
10/18/2001	CA2404971A1 Human protein kinases and protein kinase-like enzymes
10/18/2001	CA2404779A1 Human lipid binding protein 1
10/18/2001	CA2404229A1 Human transporters and ion channels
10/18/2001	CA2403946A1 Genes expressed in foam cell differentiation
10/18/2001	CA2403425A1 Multivalent antibodies and uses therefor
10/18/2001	CA2401836A1 Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
10/18/2001	CA2343602A1 Est's and encoded human proteins
10/17/2001	EP1146124A2 Gustducin materials and methods
10/17/2001	EP1146056A1 Antibodies which activate an erythropoietin receptor
10/17/2001	EP1145013A2 Removal of prions from blood, plasma and other liquids
10/17/2001	EP1145011A2 Compositions and methods for the diagnosis and treatment of tumor
10/17/2001	EP1145006A2 Detection of small molecules by use of a piezoelectric sensor
10/17/2001	EP1144998A2 Neisseria genomic sequences and methods of their use
10/17/2001	EP1144682A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
10/17/2001	EP1144678A2 Susceptibility to psoriasis
10/17/2001	EP1144671A2 Enriched central nervous system cell populations
10/17/2001	EP1144662A1 Methods and means for modification of plant characteristics using the vernalization gene vrn2
10/17/2001	EP1144651A1 Polypeptides derived from jnk3
10/17/2001	EP1144650A2 Goodpasture antigen binding protein
10/17/2001	EP1144648A1 Cyclic nucleotide-associated proteins
10/17/2001	EP1144645A1 Neisseria meningitidis polypeptide basb052
10/17/2001	EP1144644A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
10/17/2001	EP1144642A2 Compounds and methods for treatment and diagnosis of chlamydial infection
10/17/2001	EP1144640A2 Nucleic acids and proteins from streptococcus pneumoniae
10/17/2001	EP1144638A2 Chlamydia antigens and corresponding dna fragments and uses thereof
10/17/2001	EP1144636A2 Human genes and gene expression products
10/17/2001	EP1144633A1 Polypeptide
10/17/2001	EP1144632A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
10/17/2001	EP1144631A2 Insulin-synthesis genes
10/17/2001	EP1144630A2 Human cell signaling proteins (csig)
10/17/2001	EP1144629A2 Further pro polypeptides and sequences thereof
10/17/2001	EP1144628A2 Human vanilloid receptor gene
10/17/2001	EP1144625A2 Nucleic-acid binding proteins
10/17/2001	EP1144617A2 Cancer-associated proteins
10/17/2001	EP1144616A1 Method for producing antibody fragments
10/17/2001	EP1144614A2 33 human secreted proteins
10/17/2001	EP1144607A2 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
10/17/2001	EP1144605A2 Dimethylarginine dimethylaminohydrolases
10/17/2001	EP1144600A2 Akt-3 nucleic acids, polypeptides, and uses thereof
10/17/2001	EP1144598A2 Human homologues of proteins regulated by circadian rhythms
10/17/2001	EP1144454A2 Modified peptides as therapeutic agents
10/17/2001	EP1144453A1 Anti-ccr4 antibodies and methods of use therefor
10/17/2001	EP1144452A2 Modified antibodies and antibody fragments with increased duration of activity
10/17/2001	EP1144450A1 Mammalian alpha-helical protein - 12
10/17/2001	EP1144449A1 Reagents and methods useful for detecting diseases of the breast
10/17/2001	EP1144448A2 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
10/17/2001	EP1144444A2 Dnas encoding proteins with signal sequences
10/17/2001	EP1144443A2 Human membrane transport proteins
10/17/2001	EP1144442A2 Streptococcal alpha2m-binding protein
10/17/2001	EP1144439A2 Hematopoietic regulatory factors and methods of use thereof
10/17/2001	EP1144008A1 Modulation of systemic memory t cell trafficking
10/17/2001	EP1144006A2 Synergistic inhibition of hiv-1 fusion and attachment, compositions and antibodies thereto
10/17/2001	EP1143997A1 Tumor necrosis factor antagonists and their use in endometriosis
10/17/2001	EP1143993A1 Method of suppressing ongoing acute allograff rejection
10/17/2001	EP1143797A1 Methods for reducing adverse side effects associated with cellular transplantation
10/17/2001	EP1113817A4 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
10/17/2001	EP0672120B1 Production of human monoclonal antibodies active against hepatitis b surface antigen
10/17/2001	EP0618914B1 Oxiranyl methyl ethers exhibiting chirality, and their use as dopants in liquid-crystal mixtures
10/17/2001	EP0617706B1 Multivalent antigen-binding proteins
10/17/2001	EP0489149B1 Probes for detecting mutant p53
10/17/2001	CN1318103A Nucleic acids and proteins from streptococcus pneumoniae
10/17/2001	CN1318102A OMPA gene for outer membrane protein of riemerella anatipestifer and methods of use
10/17/2001	CN1318068A Nucleic acids encoding G-protein coupled receptor involved in sensory transduction
10/17/2001	CN1317976A Multicomponent vaccines
10/17/2001	CN1317569A Method for preparing mammal cell kinetin synthetic inhibitory factor
10/17/2001	CN1317343A Pharmaceutical Application of mammal cell kinetin synthetic inhibitory factor
10/17/2001	CN1073158C Anti-egfr single-chain Fvs and anti-egfr antibodies
10/17/2001	CN1073154C Superoxide dismutase-4
10/17/2001	CN1073118C Diagnostics virus of hepatitis C
10/17/2001	CN1073116C Metal-bonding cystein-free peptides, process for producing them and its pharmaceutical preparation
10/16/2001	US6303779 Process for isolating and purifying viruses and sugars from plant sources
10/16/2001	US6303771 Pth
10/16/2001	US6303769 Lerk-5 dna
10/16/2001	US6303755 Therapeutic multispecific compounds comprised of anti-FCA receptor antibodies
10/16/2001	US6303753 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
10/16/2001	US6303750 Amino acid sequences; diagnosis and treatment of rheumatoid arthritis; antiarthritic agents
10/16/2001	US6303580 Cyclitol Containing carbohydrates from human tissue which regulate lipogenic activity
10/16/2001	US6303571 To screen for antibacterial compounds; genetic immunization; therapy and prophylaxis
10/16/2001	US6303379 Transfected cells for use in treatment of genetic disorder
10/16/2001	US6303361 Human glandular kallikrein-1 (hK2)
10/16/2001	US6303344 Methods and compositions for polypeptide engineering
10/16/2001	US6303341 Genetically engineered antibody for use in immunotherapy
10/16/2001	US6303337 Adding misaminoacylated initiator trna that recognizes only the first aug codon to translation system; gene expression, evaluation; genetic engineering

1 ... 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 ... 1494